Agile Therapeutics, Inc. (NASDAQ:AGRX) Reported Basic Consolidated EPS Of $-1.3778 For Period Ended 2015-12-31

0

The annual basic consolidated EPS for Agile Therapeutics, Inc. (NASDAQ:AGRX) for the period ended 2015-12-31 was $-1.3778. On quarterly basis, the basic consolidated EPS reading for the quarter ended 2015-12-31 was $-1.3778.

EPS from continuing operations

Coming to basic EPS from continuing operations, Agile Therapeutics, Inc. (NASDAQ:AGRX) reported $-1.3778 for the annual period ended 2015-12-31. Quarterly basic EPS from continuing operations for the three-month period ended 2015-12-31 stood at $-1.3778.

EPS contribution from parent

For the annual period ended 2015-12-31, Agile Therapeutics, Inc. (NASDAQ:AGRX) received basic EPS of $-1.3778 from its parent company. On quarterly basis, basic EPS contribution from the parent company for the period ended 2015-12-31 was $-1.3778.

Basic net EPS

For the annual period ended 2015-12-31, Agile Therapeutics, Inc. (NASDAQ:AGRX) reported basic net EPS of $-1.38. On quarterly basis, the company’s basic net EPS for the three-month period ended 2015-12-31 stood at $-1.38.

Consolidated diluted EPS

The annual consolidated diluted EPS reading for the period ended 2015-12-31 stood at $-1.3778. For the quarter ended 2015-12-31, consolidated diluted EPS was $-1.3778.

Basic diluted EPS

On annual basis, diluted EPS reading from continuing operation was $-1.3778 for the period ended 2015-12-31. Diluted EPS from continuing operations for the quarter ended 2015-12-31 was $-1.3778.

Net diluted EPS

Net diluted EPS reading for the annual period ended 2015-12-31 was $-1.38. For the quarterly period ended 2015-12-31, net diluted EPS was $-1.38.

Diluted EPS from parent

From the parent company, Agile Therapeutics, Inc. (NASDAQ:AGRX) received diluted EPS of $-1.3778 for the annual period ended 2015-12-31. On quarterly basis, diluted EPS contribution from the parent for the quarter ended 2015-12-31 was $-1.3778.

Agile Therapeutics, Inc. (NASDAQ:AGRX) posted net basic EPS reading of $-1.38 for the annual period ended 2015-12-31. For the quarter, basic net EPS of $-1.38 was for the quarter ended 2015-12-31.

Net diluted EPS for Agile Therapeutics, Inc. (NASDAQ:AGRX) for the annual period ended 2015-12-31 was $-1.38. The company also reported net diluted EPS reading of $-1.38 for the quarter ended 2015-12-31.

The annual average basic shares outstanding for the period ended 2015-12-31 is 22.017 while for the quarter ended 2015-12-31 is 22.017.

The diluted shares outstanding for the fiscal year ended is 2015-12-31 is 22.017 while for the quarter ended 2015-12-31 is 22.017.

1 Chart Pattern Every Investor Should Know

This little-known pattern preceded moves of 578% in ARWR, 562% in LCI, 513% in ICPT, 439% in EGRX, 408% in ADDUS and more...

Click Here to See This Now.

(Visited 20 times, 1 visits today)